Asthma drug could halve chance of developing Parkinson’s

News

Author: Parkinson's Life editorsPublished: 28 September 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Asthma medication

A recent study has found that a drug most commonly used for asthma may cut the chances of developing Parkinson’s.

The research, carried out by Harvard Medical School, Massachusetts, US, found that those who inhaled salbutamol – a drug found in inhalers – were half as likely to develop the condition.

In Parkinson’s disease, a protein named a-synuclein accumulates in various brain cells and can be fatal. To counter this, the research team grew human nerve cells and tested over 1000 medications, finding results to suggest salbutamol could cut the production of a-synuclein.

Neurologist Anthony Lang, who works at the University of Toronto, Canada, said the results were “fascinating” and “had come out of the blue”.

Despite some encouraging developments, Clemens Scherzer, who was a part of the research team, said clinical trials were “a few years off”.

Go Back

Share this story

Comments


Related articles


Advances

Waking up to the impact of sleep disruption

Researchers look at improving sleep patterns for people with Parkinson's

READ MORE
Marty Mcfly Delorean

Perspectives

21 motivational Michael J Fox quotes on living with Parkinson’s disease

Inspiring MJ Fox quotes to mark ‘Back to the Future’ anniversary

READ MORE
Ozzy Osbourne Parkinson's

Global update

Ozzy Osbourne: “I’ve owned up to the fact that I have Parkinson’s”

The Black Sabbath singer thanks his fans for their support

READ MORE